$OMDA

Cook Steven L. sold $814K of OMDA

Cook Steven L. (Chief Financial Officer) sold 35,600 shares of Omada Health, Inc. (OMDA) at an average of $22.87 ($22.76–$23.09, $0.81M total) across 2 trades over 2026-07-01 to 2026-07-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jul 9, 2026, 12:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale amount, timing, and 10b5-1 pre-arrangement, which is typically low-signal versus earnings, guidance, or operational updates.

02

Market read

Traders may note the sale for sentiment monitoring, but it does not introduce new fundamentals or catalysts.

03

What to watch

The article does not state whether the CFO also bought shares, nor does it provide broader insider activity context beyond this single Form 4.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-08 for sales executed 2026-07-01 to 2026-07-07.

Background

The article is an SEC Form 4 insider transaction disclosure for Omada Health, Inc.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Steven L. sold about $814K of OMDA shares in two open-market trades under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal price impact; any reaction should fade unless accompanied by other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new operational or financial guidance.

Market effects

No clear sector read-through from a single CFO 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be purely liquidity-driven, especially under 10b5-1, so the market may overreact relative to the true signal.

Key entities

  • Omada Health, Inc.

    Company whose shares were sold by its CFO under a pre-arranged 10b5-1 plan.

  • Steven L. Cook

    Chief Financial Officer who executed the reported open-market sales.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch